KLBF

Kalbe Farma Tbk PT

KLBF.JK kalbe.co.id
735.00
+5.00 (+0.68%)
IDR · JK
52-week range
630.00
1,308.15
Trading at 15% of the 52-week range
Market Cap
33.26T
P/E Ratio
9.23
Forward P/E
8.68
Book Value
537.67
Div. Yield
2.65%
% Institutions
10.76%
% Insiders
64.87%

1 Year

-37.0%

3 Year

-56.6%

10 Year

-46.5%
Description

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Company Information

Company Name
Kalbe Farma Tbk PT
Sector
Healthcare
Industry
Drug Manufacturers - General
Exchange
JK
ISIN: ID1000125107
Currency: IDR
Full Time Employees: 12,806
Phone: 62 21 4287 3888
Website: kalbe.co.id
Fiscal Year End: December
IPO Date: Jul 30, 1991
Description:

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as an agent and representative for biotechnology products; distributes consumer products, medical equipment, cosmetics, and other trading products; and trades in medical and laboratory equipment and supplies, raw materials for pharmaceutical products, and consumable products for hemodialysis therapy, as well as offers advertising services. The company was incorporated in 1966 and is headquartered in Jakarta, Indonesia.

Address:

Gedung KALBE, Jakarta, Indonesia, 10510

People

Directors & Officers

Name Title Year Born
Ms. Bernadette Ruth Irawati Setiady MSc. President Director 1962
Mr. Sie Djohan Director of Corporate Business Development, Management System & Regulatory Affairs and Director 1967
Mr. Rustam Tan Head of Internal Audit Unit 1970
Maria Teresa Fabiola Corporate Secretary 1972

Financial Highlights

Market Cap: $33,257.91B
EBITDA: $5,058.58B
P/E Ratio: $9.23
PEG Ratio: $2.35
Book Value: $537.67
Dividend/Share: $20.00
Dividend Yield: 2.65%
Earnings/Share: $79.60
Profit Margin: 9.57%
Operating Margin: 11.87%
ROA (TTM): 9.22%
ROE (TTM): 14.77%
Revenue (TTM): $37,724.06B
Revenue/Share (TTM): $831.49
Earnings Growth (YOY): -0.40%
Revenue Growth (YOY): 18.20%

Valuation Metrics

Enterprise Value: $30,003.01B
Trailing P/E: 9.23
Forward P/E: 8.68

Shares Statistics

Shares Outstanding: 45.25B
Shares Float: 18.00B
% Insiders: 64.87%
% Institutions: 10.76%

Stock Price History

1 Year Price History

3 Years Price History

10 Years Price History

Financial Charts

Revenue, Net Income & Operating Cash Flow (Yearly)

Revenue, Net Income & Operating Cash Flow (Quarterly)

Operating Expenses (Yearly)

Operating Expenses (Quarterly)

Balance Sheet (Quarterly)

Assets Breakdown (Yearly)

Assets Breakdown (Quarterly)

Liabilities Breakdown (Yearly)

Liabilities Breakdown (Quarterly)

Income Statement Waterfall

Open full waterfall
Line Item
Step Type
Value
Revenue
adjust
$35,324.54B
Cost of Goods Sold
adjust
$-21,269.02B
Gross Profit
subtotal
$14,055.52B
SG&A
adjust
$-593.02B
R&D
adjust
$-499.71B
Other Operating Expense
adjust
$-8,417.78B
Operating Income
subtotal
$4,545.02B
Other / Non-Operating Items
adjust
$-880.02B
Net Income
subtotal
$3,665.00B

Earnings Per Share (EPS) History

Financial Ratios

📦 Raw API Data (JSON Explorer)

Assistant

×
Hello! I'm your AI assistant. I have access to the financial data on this page. Ask me anything about KLBF.JK!